Related Experiment Video

Updated: Jan 11, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
07:20

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents

Published on: May 28, 2014

14.4K

Structure-Based Design and Optimization of Bi-Aryl Amide Derivatives as Nur77 Ligands for Nur77-Bcl-2-Dependent

Taige Zhao1, Jun Chen1, Wenbin Hong2

  • 1State Key Laboratory of Cellular Stress Biology and Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Science, Xiamen University, Xiamen 361102, China.

Journal of Medicinal Chemistry
|November 17, 2025
PubMed

Insights

The novel compound NF1 effectively targets the Nur77 receptor, a key player in cancer progression. NF1 induces cancer cell death via the Nur77/Bcl-2 pathway and shows significant antitumor effects in vivo.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Nur77 (NR4A nuclear receptor) is crucial in tumorigenesis and cancer progression.
  • Activating Nur77's nongenomic functions offers therapeutic potential in oncology.
  • Previous work identified NB1 as a Nur77 ligand inducing apoptosis.

Purpose of the Study:

  • To develop and evaluate NF1, a novel Nur77 ligand with improved binding affinity and stability.
  • To assess NF1's efficacy in inducing apoptosis and its in vivo antitumor activity.

Main Methods:

  • Structure-based optimization of NB1 to create NF1.
  • Evaluation of Nur77 binding, mitochondrial translocation, and apoptosis induction.
  • In vivo antitumor efficacy studies, pharmacokinetic analysis, and safety profiling (LD50).

Main Results:

  • NF1, derived from NB1, exhibits enhanced Nur77-binding affinity and stability.
  • NF1 effectively induces apoptosis through the Nur77/Bcl-2 pathway.
  • NF1 demonstrates significant in vivo antitumor efficacy with a favorable safety profile (LD50 > 500 mg/kg).

Conclusions:

  • NF1 is a potent Nur77-targeting compound with promising therapeutic potential for cancer treatment.
  • NF1 represents a viable candidate for further preclinical and clinical development in oncology.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

1.9K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.8K

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Nomenclature of Aryl and Heterocyclic Amines01:10

Nomenclature of Aryl and Heterocyclic Amines

The simplest aromatic amine is phenylamine, which contains an –NH2 functionality directly attached to an aromatic ring. The name aniline is designated for this skeleton. As shown in Figure 1, the common names of the functionalized anilines involve prefixes ortho-, meta-, and para- to indicate the substitution position. Different functionalized aniline derivatives also have notable trivial names.
3.0K